Anand Singh
Affiliations: | 2022- | Symptom Research | University of Texas M.D. Anderson Cancer Center |
Google:
"Anand Singh"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Peter M. Grace | grad student | 2022- | University of Texas M.D. Anderson Cancer Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Singh AK, Ruiz D, Ur Rasheed MS, et al. (2024) Systemic and targeted activation of Nrf2 reverses doxorubicin-induced cognitive impairments and sensorimotor deficits in mice. Biorxiv : the Preprint Server For Biology |
| Yap TA, Daver N, Mahendra M, et al. (2023) Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature Medicine |
| Singh AK, Mahalingam R, Squillace S, et al. (2022) Targeting the A adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice. Acta Neuropathologica Communications. 10: 11 |
| McAlpin BR, Mahalingam R, Singh AK, et al. (2022) HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity. Theranostics. 12: 603-619 |